Same Indication

Ondansetron vs Rituximab

Ondansetron vs Rituximab: Overview

This comparison examines the pharmacological differences between Ondansetron and Rituximab.

Mechanism of Action

Ondansetron: Selective 5-HT3 receptor antagonist.

Rituximab: Chimeric anti-CD20 IgG1 monoclonal antibody inducing B-cell depletion via CDC, ADCC, and apoptosis.

Pharmacokinetics

Half-life: Ondansetron — 3-5 hours; Rituximab — 22 days.

Chemical Properties

Molecular Formula: Ondansetron — C18H19N3O.

Molecular Weight: Ondansetron — 293.3660 g/mol.

Type: Ondansetron — Small molecule; Rituximab — Antibody.